“In paired intra-animal post-inoculation comparison made in this limited study, fewer colony forming units of pathogenic bacteria accumulated at the tip of the side-hole-free catheters than at the tips of the catheters which have side holes” Tal et al (2021).
“These results suggest that in individuals with cancer, the use of a CVR ≤45% should be considered to minimise risk of thrombosis” Sharp et al (2021).
“Laboratory tests drawn by the Pull-push method could replace peripheral vein phlebotomy to avoid the trauma associated with venipuncture and infection risk” Lokeskrawee et al (2021).
“A case for biologics (infusion vs subcutaneous) must be made on accurate real-world economic analysis” Heald et al (2021).
“This significant reduction (by Fisher’s exact test p = 0.0001) suggests that employing a passive blood diversion device in addition to targeted education may decrease FPBCs; antibiotics overuse, costs, and return visits in the pediatric ED setting” Ostwald et al (2021).
“Our results showed that 0.9% NaCl and 0.45% NaCl solutions might be the safest and the most appropriate fluids to maintain normal plasma osmolality in medical situations requiring fluid therapy with high or maintenance rates, respectively” Keskin et al (2021).
“The tool we describe (RAVESTO-Rapid Assessment of Vascular Exit Site and Tunneling Options) defines the different options of subcutaneous tunneling and their indications in different clinical situations in patients with complex vascular access” Ostroff et al (2021).